Chimeric antigen receptor T cells applied to solid tumors

Chimeric antigen receptor T cell (CAR-T) therapy is novel tumor immunotherapy that enables autologous T to express synthetic receptors to specifically recognize the surface tumor-associated antigens for exerting subsequent antitumor effects, and eliminating the resistance, metastases and recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhongguo, Tao, Can, Li, Jianting, Tang, Johnny Cheuk-on, Chan, Albert Sun-chi, Zhou, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659902/
https://www.ncbi.nlm.nih.gov/pubmed/36389701
http://dx.doi.org/10.3389/fimmu.2022.984864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659902/
https://www.ncbi.nlm.nih.gov/pubmed/36389701
http://dx.doi.org/10.3389/fimmu.2022.984864

Ejemplares similares